These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21621740)

  • 21. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
    Osman I; Segar L
    Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
    Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
    Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells.
    Hsieh HL; Sun CC; Wu CB; Wu CY; Tung WH; Wang HH; Yang CM
    J Cell Biochem; 2008 Apr; 103(6):1732-46. PubMed ID: 17902169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of ribosylated-BSA in regulating PC12 cell viability.
    Kuo TY; Huang CL; Yang JM; Huang WJ; Huang NK; Chen YW; Lin RJ; Yang YC
    Cell Biol Toxicol; 2012 Aug; 28(4):255-67. PubMed ID: 22543687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-D-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding.
    Mahali SK; Manna SK
    Biochem Pharmacol; 2012 Dec; 84(12):1681-90. PubMed ID: 23058985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
    Ruiz E; Redondo S; Gordillo-Moscoso A; Tejerina T
    J Pharmacol Exp Ther; 2007 May; 321(2):431-8. PubMed ID: 17267584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.
    Kato K; Satoh H; Endo Y; Yamada D; Midorikawa S; Sato W; Mizuno K; Fujita T; Tsukamoto K; Watanabe T
    Biochem Biophys Res Commun; 1999 May; 258(2):431-5. PubMed ID: 10329404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A; Wu L; Wang R; de Champlain J
    Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pioglitazone inhibits advanced glycation end product-induced TNF-α and MMP-13 expression via the antagonism of NF-κB activation in chondrocytes.
    Chen C; Ma C; Zhang Y; Zeng Y; Li Y; Wang W
    Pharmacology; 2014; 94(5-6):265-72. PubMed ID: 25471680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells.
    Iwashima Y; Eto M; Horiuchi S; Sano H
    Biochem Biophys Res Commun; 1999 Oct; 264(2):441-8. PubMed ID: 10529383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation.
    Liu HB; Hu YS; Medcalf RL; Simpson RW; Dear AE
    Biochem Biophys Res Commun; 2005 Aug; 334(1):30-7. PubMed ID: 15990085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular regulation of resistin expression in cultured vascular smooth muscle cells under hypoxia.
    Hung HF; Wang BW; Chang H; Shyu KG
    J Hypertens; 2008 Dec; 26(12):2349-60. PubMed ID: 19008713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells.
    Ichiki T; Tokunou T; Fukuyama K; Iino N; Masuda S; Takeshita A
    Biochem Biophys Res Commun; 2004 Oct; 323(2):402-8. PubMed ID: 15369766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta.
    Toba H; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Murakami M; Morita Y; Nakayama Y; Kobara M; Nakata T
    Eur J Pharmacol; 2006 Nov; 549(1-3):124-32. PubMed ID: 16979161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pioglitazone, a PPARgamma ligand, suppresses NFkappaB activation through inhibition of IkappaB kinase activation in cerulein-treated AR42J cells.
    Wan H; Yuan Y; Qian A; Sun Y; Qiao M
    Biomed Pharmacother; 2008 Sep; 62(7):466-72. PubMed ID: 18490130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
    Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
    Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.
    Sangle GV; Zhao R; Shen GX
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1243-54. PubMed ID: 18796547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.
    Gao H; Li H; Li W; Shen X; Di B
    Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of insulin signaling on vascular smooth muscle cell migration, proliferation, and inflammation pathways.
    Cersosimo E; Xu X; Musi N
    Am J Physiol Cell Physiol; 2012 Feb; 302(4):C652-7. PubMed ID: 22094332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.
    Feener EP; Northrup JM; Aiello LP; King GL
    J Clin Invest; 1995 Mar; 95(3):1353-62. PubMed ID: 7883982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.